Bristol-Myers Squibb Co. (NYSE: BMY) May Be Attracting Institutional Investments

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NYSE listed company, BMY falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Bristol-Myers Squibb Co. is $91.34B. A total of 11.81 million shares were traded on the day, compared to an average of 15.32M shares.

In the most recent transaction, BOERNER CHRISTOPHER S. bought 2,000 shares of BMY for 49.78 per share on Dec 05 ’23. After the transaction, the Chief Executive Officer now owns 82,672 company shares. In a previous transaction on Nov 28 ’23, BOERNER CHRISTOPHER S. bought 3,071 shares at 48.86 per share. BMY shares that Chief Executive Officer owns now total 79,384.

Among the insiders who bought shares, Samuels Theodore R. II acquired of 8,500 shares on Nov 20 ’23 at a per-share price of $49.81. This resulted in the Director holding 35,500 shares of BMY after the transaction. In another insider transaction, Powell Ann sold 17,986 shares at $61.25 per share on Aug 24 ’23. Company shares held by the EVP, Chief Human Resources now total 27,868.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. BMY’s most recent ex-dividend date was 4/4/2024 when it declared a $0.60 quarterly dividend that was paid in cash on 5/1/2024. Previously, the company paid the dividend on 2/1/2024 with an ex-dividend date of 1/4/2024. The BMY stock dividend was $0.60 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BMY has a high of $69.10 and a low of $43.33.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $8.14, while its Total Shareholder’s Equity was $36.01B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.32.

Most Popular

Related Posts